Stories Tagged as
COVID-19 vaccine
How Pennsylvania plans to handle COVID vaccine distribution
by
David Brancaccio
and Daniel Shin
Nov 25, 2020
Pennsylvania Secretary of Health Dr. Rachel Levine says she's confident in the state's plan for rolling out vaccines.
Dow crests 30,000 on vaccine hopes, Biden transition
Nov 24, 2020
Investors were encouraged by the latest vaccine progress and news that the transition of power in the U.S. will finally begin.
Getting states prepared to distribute COVID vaccines
by
David Brancaccio
, Daniel Shin
and Alex Schroeder
Nov 24, 2020
The list includes funding, a plan for communicating with the public, medical personnel training and storage capabilities.
AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race
by
Scott Tong
Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.
Is a deeper dollar slump ahead as vaccine nears?
Nov 23, 2020
Safer currencies beckon global investors as COVID rates keep climbing in the U.S.
Oxford-AstraZeneca vaccine may pose fewer distribution challenges
by
David Brancaccio
, Victoria Craig
and Alex Schroeder
Nov 23, 2020
That would be an advantage particularly for getting a COVID-19 vaccine to developing countries.
Pfizer to ask today for emergency vaccine authorization
by
David Brancaccio
, Jasmine Garsd
and Alex Schroeder
Nov 20, 2020
Emergency authorization means the FDA facilitates availability of the vaccine during a declared state of emergency.
For public good, not for profit.
How might COVID-19 vaccine makers compete in the marketplace?
by
Andy Uhler
Nov 17, 2020
At first, COVID-19 vaccines won't be marketed in the usual sense, because the government will be the main buyer.
Top central bankers: Economy needs help despite vaccine news
Nov 13, 2020
U.S. Federal Reserve Chair Jerome Powell said Congress “may need to do more” to cushion the blow from the pandemic.
Moderna says it can start analyzing how well its COVID-19 vaccine works
Nov 12, 2020
Moderna's clinical trial has accumulated sufficient data on volunteers with infections to analyze vaccine efficacy.